Star Scientific Shares Quiet Following Response to Two Plaintiffs' Class Action Suits, Multiple Press Releases

 Paul L. Perito, Esquire, Chairman, President and COO of Star Scientific, Inc. STSI, issued the following statement on behalf of Star Scientific and Rock Creek Pharmaceuticals, Inc.: Numerous plaintiffs' class action law firms have been issuing press releases and announcements since January seeking potential plaintiffs to retain them and sue the Company.  These press releases and announcements that are appearing on various websites and in other media are not lawsuits.  They are attempts by plaintiffs' firms to solicit plaintiffs to form class action lawsuits.  As of today, two shareholder complaints have been filed against Star Scientific. The first complaint, filed in the United States District Court for the Eastern District of Virginia on March 25, 2013, is named Reuter v. Star Scientific, Inc., et al.  A second complaint, subsequently filed in the United States District Court for the District of Massachusetts on March 26, 2013, is named Boravian v. Star Scientific, Inc., et al.  We believe that both of these complaints are without merit and we will assert numerous defenses to the claims being made.  We have hired able and experienced trial counsel who have successfully defended similar class action cases.  We will vigorously defend these suits, and we believe that we will ultimately be successful.  Star Scientific will not be deterred by these distractions, as we stated last week.  The Company is proud of its worthy science based products, as well as the fact that these products are used by thousands of satisfied, repeat customers.  We stand behind our scientific research, and that of other credentialed third parties, which has been conducted on our anatabine compound, as well as the reporting of the results of that research.  Accordingly, the Company will continue to focus on sales of its Anatabloc® products, its new Anatabloc® facial creme, and the extension of its product line.